Redcare Pharmacy N.V. (SAEYY) Stock Analysis
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Redcare Pharmacy N.V. (SAEYY) trades at $7.00 with AI Score 46/100 (Grade C). Redcare Pharmacy NV is a European online pharmacy operating in multiple countries, including Germany and the Netherlands. Market cap: $1.41B, Sector: Healthcare.
Price as of Aug 21, 2026 · Last analyzed: Mar 16, 2026Analyst Coverage for SAEYY: SAEYY does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates SAEYY against Healthcare peers across nine fundamental dimensions and assigns an underweight signal based on the underlying data.
SAEYY: 1/3 scored disciplines lean bearish. Dominant signal: Ken Griffin bullish.
How is this calculated? →Why this analysis is different
- A 9-signal quantitative MoonshotScore built from filings, insider activity, and market data — computed from the numbers, not from opinion.
- An AI Council read across up to eight perspectives — value, macro, quantitative, and momentum lenses — that shows where they disagree instead of averaging the tension away.
- Figures come straight from FMP and Yahoo Finance filings data. The AI writes the narrative around the numbers — it never edits the numbers.
Redcare Pharmacy N.V. (SAEYY) Healthcare & Pipeline Overview
Redcare Pharmacy NV, a leading online pharmacy in Europe, provides prescription and over-the-counter medications, beauty, and personal care products across multiple countries. With a focus on digital healthcare solutions, Redcare operates in a competitive landscape, balancing growth with profitability amid evolving regulations and consumer preferences.
What Is the Investment Thesis for SAEYY?
Redcare Pharmacy NV presents a mixed investment case. The company's presence in the growing online pharmacy market across Europe offers potential for revenue expansion. However, its negative profit margin of -1.3% and negative ROE of -8.0% raise concerns about profitability. With a debt-to-equity ratio of 86.94, the company has a notable amount of leverage. Investors should closely monitor Redcare's ability to improve its financial performance and manage its debt effectively. Key growth catalysts include expanding its product offerings and increasing its market share in existing and new geographies. The company's beta of 1.07 indicates that it is slightly more volatile than the market.
Based on FMP financials and quantitative analysis
SAEYY Key Highlights
Market capitalization of $1.41B reflects investor valuation of Redcare Pharmacy NV.
- Gross margin of 22.5% indicates the company's profitability after deducting the cost of goods sold.
- Debt-to-equity ratio of 86.94 suggests a leveraged capital structure.
- Negative profit margin of -1.3% highlights the company's current challenges in achieving profitability.
- Beta of 1.07 indicates that the stock is slightly more volatile than the market.
Who Are SAEYY's Competitors?
SAEYY is benchmarked below against 3 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| AMZN Amazon.com, Inc. | $260.90 | -1.86% | $2.81T | 71 |
| WBA Walgreens Boots Alliance operates as a pharmacy-led health and beauty retail company with a global presence. The company | $11.98 | +0.50% | $10.4B | 45 |
| CVS CVS Health Corporation | $93.65 | -1.33% | $119B | 70 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are SAEYY's Key Strengths?
Established online presence in multiple European countries.
- Wide range of products and services.
- Convenient and accessible platform.
- Focus on customer service.
What Are SAEYY's Weaknesses?
Negative profit margin.
- Negative return on equity.
- High debt-to-equity ratio.
- Reliance on online sales channel.
What Could Drive SAEYY Stock Higher?
Potential expansion into new European markets could drive revenue growth.
- Increasing adoption of digital healthcare services may boost customer acquisition and retention.
- Strategic partnerships with healthcare providers could expand market reach.
- Product diversification and enhanced offerings may attract new customer segments.
What Are the Key Risks for SAEYY?
Negative return on equity (-9.0%) — the business is not currently generating profit on shareholder capital.
- Weak fundamentals — a Piotroski F-Score of 2/9 flags soft profitability, leverage or efficiency.
- Intense competition from established online and brick-and-mortar pharmacies could limit market share gains.
- Stringent regulations in the pharmaceutical industry could impact operations and profitability.
- Fluctuations in currency exchange rates could affect financial performance.
- Changes in consumer preferences and buying habits could impact sales.
- Negative profit margin and high debt levels pose financial sustainability concerns.
What Are the Growth Opportunities for SAEYY?
- Expansion into new European markets represents a significant growth opportunity for Redcare Pharmacy NV. By extending its operations into underserved regions, the company can tap into new customer bases and increase its overall market share. This expansion strategy requires careful consideration of local regulations, cultural nuances, and competitive dynamics. Successful market entry could substantially boost Redcare's revenue and profitability, contributing to long-term growth.
- Increasing the adoption of digital healthcare services, such as online consultations and remote monitoring, can drive growth for Redcare Pharmacy NV. By offering these value-added services, the company can attract new customers and enhance customer loyalty. The market for digital healthcare services is expanding rapidly, driven by technological advancements and changing consumer expectations. Redcare's ability to integrate these services into its platform will be crucial for its future success.
- Developing strategic partnerships with healthcare providers and insurance companies can create new avenues for growth. By collaborating with these entities, Redcare Pharmacy NV can gain access to a wider customer base and integrate its services into existing healthcare ecosystems. These partnerships can also facilitate the development of innovative healthcare solutions and improve patient outcomes. The healthcare industry is increasingly focused on collaboration and integration, making strategic partnerships essential for long-term growth.
- Enhancing the product offerings to include a wider range of healthcare and wellness products can attract new customers and increase sales. By expanding its product portfolio, Redcare Pharmacy NV can cater to a broader range of customer needs and preferences. This expansion strategy requires careful market research and product development. Successful product diversification can significantly boost Redcare's revenue and profitability.
- Leveraging data analytics to personalize the customer experience and optimize marketing efforts can drive growth for Redcare Pharmacy NV. By analyzing customer data, the company can gain insights into customer preferences, behaviors, and needs. This information can be used to personalize product recommendations, tailor marketing messages, and improve customer service. The use of data analytics is becoming increasingly important in the e-commerce industry, and Redcare's ability to leverage this technology will be crucial for its future success.
What Are SAEYY's Competitive Advantages?
- Established online presence and brand recognition in multiple European countries.
- Wide range of products and services catering to diverse customer needs.
- Convenient and accessible platform for purchasing medications and healthcare products.
- Focus on customer service and building customer loyalty.
What Does SAEYY Do?
Founded in 2001 and based in Sevenum, Netherlands, Redcare Pharmacy NV, formerly known as Shop Apotheke Europe N.V., has evolved into a prominent online pharmacy operating across the Netherlands, Germany, Italy, Belgium, Switzerland, Austria, and France. The company's core business revolves around offering a wide array of pharmaceutical and healthcare-related products directly to consumers through its online platform. These products include both prescription and non-prescription over-the-counter medications, beauty and personal care items, and food supplements. Redcare Pharmacy aims to provide convenient and accessible healthcare solutions to its customers, leveraging the growing trend of online shopping and digital healthcare services. The company changed its name to Redcare Pharmacy NV in June 2023, marking a new chapter in its corporate identity. Redcare faces competition from traditional brick-and-mortar pharmacies, as well as other online retailers in the healthcare space. Its success depends on its ability to maintain competitive pricing, ensure timely delivery, and comply with evolving regulations in the pharmaceutical industry.
What Products and Services Does SAEYY Offer?
- Operates online pharmacy business in multiple European countries.
- Offers prescription medications online.
- Sells non-prescription over-the-counter pharmaceuticals.
- Provides beauty and personal care products.
- Offers food supplements.
- Delivers medications and healthcare products directly to customers' homes.
How Does SAEYY Make Money?
- Generates revenue through the sale of pharmaceutical and healthcare-related products online.
- Offers a convenient and accessible platform for customers to purchase medications and other healthcare products.
- Focuses on providing a wide range of products and services to meet the diverse needs of its customers.
What Industry Does SAEYY Operate In?
Redcare Pharmacy NV operates within the pharmaceutical retail industry, which is undergoing a significant shift towards online channels. The European e-pharmacy market is experiencing growth, driven by increasing internet penetration, changing consumer preferences, and the convenience of online shopping. However, the industry is also subject to stringent regulations and intense competition. Redcare competes with traditional brick-and-mortar pharmacies, as well as other online retailers. The company's success depends on its ability to navigate the regulatory landscape, differentiate its offerings, and maintain competitive pricing.
Who Are SAEYY's Key Customers?
- Individuals seeking prescription medications.
- Consumers looking for over-the-counter pharmaceuticals.
- Customers interested in beauty and personal care products.
- Individuals seeking food supplements and wellness products.
Forward Outlook
Wall Street analysts project Redcare Pharmacy N.V. revenue of about $3.41B for fiscal 2026, with EPS near $0.00. The estimate reflects 9 contributing analysts.
Quarterly Financial Performance: Redcare Pharmacy N.V.
Revenue for Redcare Pharmacy N.V. came in at $853.5M during Q2 2026, a 1.2% contraction versus the preceding quarter. The company recorded net income of $4.7M, with diluted EPS of $0.02. Quarter-over-quarter revenue has been mixed, typical for a small-cap company operating in Healthcare. Across the four most recent quarters, SAEYY averaged $-0.05 in diluted EPS.
SAEYY Valuation & Market Position
With a $1.41B market cap, Redcare Pharmacy N.V. sits in the small-cap segment of the market. Relative to its peer group, SAEYY's quantitative score of 46/100 is below the peer average of 62/100.
Key Financial Metrics
Return on equity for Redcare Pharmacy N.V. stands at -9.0%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is -3.6%, showing how much profit it generates from its asset base. Its free cash flow yield is -7.7%, a gauge of the cash the business throws off relative to its market value. A current ratio of 1.59 indicates the company holds enough short-term assets to cover its near-term obligations. Its earnings yield is -3.3%, the inverse of the P/E and a quick read on earnings relative to price.
Financial Health
Redcare Pharmacy N.V.'s Piotroski F-Score is 2/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny. Its Altman Z-Score of 3.61 places it in the safe zone, indicating low near-term bankruptcy risk.
Company Profile
Redcare Pharmacy N.V. operates in the Medical - Distribution industry within the Healthcare sector. It is headquartered in Sevenum, NL. The company is led by CEO Olaf Heinrich. SAEYY has traded publicly since 2020.
SAEYY Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis · FY 2025
Bull Case vs Bear Case
Bull Case
- Established online presence in multiple European countries.
- Wide range of products and services.
- Convenient and accessible platform.
- Focus on customer service.
Bear Case
- Negative profit margin.
- Negative return on equity.
- High debt-to-equity ratio.
- Reliance on online sales channel.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · August 2026
Recent Quarterly Results
| Quarter | Revenue | Net Income | EPS |
|---|---|---|---|
| Q2 2026 | $854M | $5M | $0.02 |
| Q1 2026 | $863M | -$11M | -$0.05 |
| Q4 2025 | $788M | -$29M | -$0.14 |
| Q3 2025 | $719M | -$7M | -$0.04 |
Based on FMP financials and quantitative analysis
SAEYY Latest News
No recent news available for SAEYY.
SAEYY Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for SAEYY.
Price Targets
Wall Street price target analysis for SAEYY.
SAEYY MoonshotScore
What does this score mean?
The MoonshotScore rates SAEYY 0-100 on quantitative fundamentals — growth, financial health, valuation, momentum, and risk.
Redcare Pharmacy N.V. ADR Information Unsponsored
Redcare Pharmacy N.V. (SAEYY) trades in the U.S. as an American Depositary Receipt (ADR).
- ADR Level: 1
- ADR Ratio: 1:1
- Home Market Ticker: SAEY
SAEYY OTC Market Information
The OTC Other tier represents the lowest tier of the OTC market, indicating that Redcare Pharmacy NV may not meet the minimum financial or disclosure requirements for higher tiers like OTCQX or OTCQB. Companies in this tier may have limited financial reporting and may not be subject to the same level of regulatory scrutiny as those listed on major exchanges like the NYSE or NASDAQ. Investing in companies on the OTC Other tier carries higher risks due to the potential for less transparency and liquidity.
- OTC Tier: OTC Other
- Limited financial disclosure increases information asymmetry.
- Lower trading volume and liquidity can lead to price volatility.
- OTC listing may indicate the company does not meet listing requirements of major exchanges.
- Potential for less regulatory oversight compared to exchange-listed companies.
- Higher risk of fraud or manipulation due to less stringent listing standards.
- Verify the company's financial statements and audit reports.
- Research the company's management team and their track record.
- Assess the company's business model and competitive landscape.
- Review the company's legal and regulatory filings.
- Monitor trading volume and price volatility.
- Understand the risks associated with investing in OTC stocks.
- Consult with a financial advisor before investing.
- Company has been in operation since 2001.
- Operates in a regulated industry (pharmaceuticals).
- Presence in multiple European countries suggests a degree of operational scale.
- Name change in 2023 may indicate a strategic shift or rebranding effort.
What Investors Ask About Redcare Pharmacy N.V. (SAEYY) — Healthcare
What does the AI Score mean for SAEYY?
SAEYY holds an AI Score of 46/100 (Grade: C). This is an educational research signal, not a buy or sell recommendation. Redcare Pharmacy NV is a European online pharmacy operating in multiple countries, including Germany and the Netherlands. The company offers prescription and over-the-counter medications, along …
What does Redcare Pharmacy NV do?
Redcare Pharmacy NV operates as an online pharmacy business, primarily serving customers in the Netherlands, Germany, Italy, Belgium, Switzerland, Austria, and France. The company provides a convenient platform for customers to purchase prescription and non-prescription over-the-counter pharmaceuticals, beauty and personal care products, and food supplements. By leveraging its online presence, Redcare aims to offer accessible healthcare solutions and cater to the growing demand for digital pharmacy services in Europe.
What are the main risks for SAEYY?
Redcare Pharmacy NV faces several risks, including intense competition from established online and brick-and-mortar pharmacies, stringent regulations in the pharmaceutical industry, fluctuations in currency exchange rates, and changes in consumer preferences. The company's negative profit margin and high debt levels also pose financial sustainability concerns. Investors should carefully consider these risks before investing in SAEYY.
What are the key factors to evaluate for SAEYY?
Redcare Pharmacy N.V. (SAEYY) holds an AI score of 46/100 (low). Redcare Pharmacy NV presents a mixed investment case. Not financial advice.
How frequently does SAEYY data refresh on this page?
SAEYY's price was last updated on Aug 21, 2026 and refreshes on page view during U.S. market hours — it is not a real-time exchange feed. Fundamentals update after quarterly filings; the MoonshotScore recalculates nightly; news aggregates continuously.
What has driven SAEYY's recent stock price performance?
Redcare Pharmacy N.V. (SAEYY) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Established online presence in multiple European countries. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider SAEYY overvalued or undervalued right now?
Redcare Pharmacy N.V. (SAEYY) has no trailing P/E available here, so lean on price-to-sales and cash flow in the Financials tab. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
How do I research SAEYY before investing?
Before investing in Redcare Pharmacy N.V. (SAEYY), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) analyst consensus ratings and price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Why might investors consider adding SAEYY to a portfolio?
Key strength of Redcare Pharmacy N.V. (SAEYY): Established online presence in multiple European countries. Weigh rewards against risks and diversify. Not financial advice.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- AI analysis pending for SAEYY, limiting the depth of insights.
- OTC market stocks carry higher risk than exchange-listed stocks.